- US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports Reuters
- Medicare, Medicaid plan to experiment with covering weight loss drugs The Washington Post
- Trump officials plan coverage for weight loss drugs under Medicare and Medicaid The Guardian
- Medicare, Medicaid to try coverage of GLP-1s for obesity, report says Axios
- Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem. Barron’s
Source link
